
CJC-1295 + Ipamorelin
CJC-1295 + Ipamorelin is a combination peptide protocol that pairs two complementary signaling peptides — a growth hormone–releasing hormone (GHRH) analog and a selective growth hormone secretagogue. Together, they are associated with supporting the body's natural pulsatile release of growth hormone, which is why this combination has become one of the most discussed protocols in conversations around vitality, recovery, body composition, and healthy aging.
CJC-1295 + Ipamorelin is frequently explored in discussions around lean body composition support, sleep quality, recovery, and overall regenerative care. It is one of the better-known peptide combinations in longevity and performance-focused conversations, valued for its targeted approach to growth hormone signaling.
Choose options



How It Works
Why People Are Interested
Benefits
Who Can Benefit
Why Evaluation Matters
Treatment Process
Every program at Evolve follows a structured clinical model:
Comprehensive testing reveals your current physiology
Patterns, imbalances, and risk markers are identified
Treatment is selected based on objective data
Ongoing testing ensures safety and effectiveness
Schedule a Peptide Consultation
Discuss whether this approach may be appropriate as part of your personalized care plan.
